Abstract:BackgroundMultiple computational methods for predicting drug-target interactions have been developed to facilitate the drug discovery process. These methods use available data on known drug-target interactions to train classifiers with the purpose of predicting new undiscovered interactions. However, a key challenge regarding this data that has not yet been addressed by these methods, namely class imbalance, is potentially degrading the prediction performance. Class imbalance can be divided into two sub-problems. Firstly, the number of known interacting drug-target pairs is much smaller than that of non-interacting drug-target pairs. This imbalance ratio between interacting and non-interacting drug-target pairs is referred to as the between-class imbalance. Between-class imbalance degrades prediction performance due to the bias in prediction results towards the majority class (i.e. the non-interacting pairs), leading to more prediction errors in the minority class (i.e. the interacting pairs). Secondly, there are multiple types of drug-target interactions in the data with some types having relatively fewer members (or are less represented) than others. This variation in representation of the different interaction types leads to another kind of imbalance referred to as the within-class imbalance. In within-class imbalance, prediction results are biased towards the better represented interaction types, leading to more prediction errors in the less represented interaction types.ResultsWe propose an ensemble learning method that incorporates techniques to address the issues of between-class imbalance and within-class imbalance. Experiments show that the proposed method improves results over 4 state-of-the-art methods. In addition, we simulated cases for new drugs and targets to see how our method would perform in predicting their interactions. New drugs and targets are those for which no prior interactions are known. Our method displayed satisfactory prediction performance and was able to predict many of the interactions successfully.ConclusionsOur proposed method has improved the prediction performance over the existing work, thus proving the importance of addressing problems pertaining to class imbalance in the data.

SFLLN: A Sparse Feature Learning Ensemble Method with Linear Neighborhood Regularization for Predicting Drug–drug Interactions

A Molecular Fragment Representation Learning Framework for Drug–Drug Interaction Prediction

[Screening for malignant gynecologic tumors].

Drug-target interaction prediction via class imbalance-aware ensemble learning

DrugSK: A Stacked Ensemble Learning Framework for Predicting Drug Combinations of Multiple Diseases

DrugECs: An Ensemble System with Feature Subspaces for Accurate Drug-Target Interaction Prediction

DrugE-Rank: improving drug-target interaction prediction of new candidate drugs or targets by ensemble learning to rank.

Potassium hydroxide solution 10% for the fast hydrolysis of esters for analysis.

DeepDrug: A General Graph-Based Deep Learning Framework for Drug-Drug Interactions and Drug-Target Interactions Prediction

Multi-Label Robust Factorization Autoencoder and its Application in Predicting Drug-Drug Interactions

Integrative approach for predicting drug-target interactions via matrix factorization and broad learning systems

Enhancing Drug-Drug Interaction Prediction Using Deep Attention Neural Networks

SSF-DDI: a deep learning method utilizing drug sequence and substructure features for drug–drug interaction prediction

Deoxycoformycin antagonizes ischemia-induced neuronal degeneration

Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures

Drug-target interaction prediction using high order nonlinear features via neural factorization machines

CNN-DDI: a learning-based method for predicting drug–drug interactions using convolution neural networks

Synergizing Convolutional Neural Networks and Drug Similarity Estimation for Improved Drug-Drug Interaction Prediction

A Novel Drug–Target Interaction Prediction Model Using Neural Fingerprint and Self-Attention Mechanism

Molecular Substructure-Aware Network for Drug-Drug Interaction Prediction

Learning from low-rank multimodal representations for predicting disease-drug associations